Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-17

Clinical Trial Update: A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of risperidone and olanzapine on blood glucose in patients with schizophrenia or schizoaffective disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)
  • Zyprexa (olanzapine)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia, Diabetes Mellitus | Phase 4 | Status: COMPLETED